Related Experiment Video
Updated: Oct 29, 2025

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases
Published on: September 29, 2014
Longitudinal motor function in proximal versus distal DMD pathogenic variants.
Mathula Thangarajh1, Luca Bello2, Heather Gordish-Dressman3
1Department of Neurology, Virginia Commonwealth University, Richmond, Virginia, USA.
The location of dystrophin gene (DMD) pathogenic variants does not impact upper or lower limb motor function decline in Duchenne muscular dystrophy (DMD). Age is the primary factor influencing motor function trajectories in DMD patients.
Area of Science:
- Neurology
- Genetics
- Clinical Medicine
Background:
- Duchenne muscular dystrophy (DMD) presents with significant clinical outcome variability.
- Understanding factors influencing DMD progression is crucial for patient management.
Purpose of the Study:
- To investigate if the location of dystrophin gene (DMD) pathogenic variants affects upper and lower extremity motor function in a large DMD cohort.
- To analyze motor function trajectories based on proximal versus distal DMD variant locations.
Main Methods:
- Longitudinal motor function data from 154 boys with DMD over 10 years were analyzed.
- Patients were categorized by DMD variant location: proximal (5' intron 44) vs. distal (including intron 44).
- Upper and lower extremity motor function measures were compared, adjusting for corticosteroid use.
Main Results:
- No significant difference in time to loss-of-ambulation or limb motor function trajectories between proximal and distal variant groups.
- Age significantly impacted motor function: younger boys (<7 years) showed functional gains, while older boys (≥7 years) exhibited decline.
- Motor function decline was independent of DMD variant location.
Conclusions:
- Proximal versus distal DMD pathogenic variant location does not influence the longitudinal decline in upper or lower motor function.
- Age is a critical determinant of motor function progression in Duchenne muscular dystrophy.
More Related Videos
09:18Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
05:16Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
Published on: May 7, 2020